Form 4: Cumberland Pharma Director Boosts Stake via 10b5-1 Plan

Cumberland Pharmaceuticals Director Kenneth Krogulski acquired 1,916 shares of common stock in December 2025 through a pre-arranged 10b5-1 trading plan.

Summary

• Kenneth Krogulski, a Director of Cumberland Pharmaceuticals Inc. (CPIX), acquired a total of 1,916 shares of common stock during December 2025.
• The transactions occurred between December 1, 2025, and December 31, 2025, at varying prices ranging from $2.24 to $4.32 per share.
• These purchases were executed automatically pursuant to a Rule 10b5-1 trading plan, which Mr. Krogulski adopted on November 14, 2024.
• Following these transactions, Mr. Krogulski's direct beneficial ownership of Common Stock increased from 294,746 shares to 296,538 shares.

Sentiment

Score: 7

Explanation: The consistent acquisition of shares by a director, even through a pre-arranged plan, generally indicates a positive long-term outlook and confidence in the company's value, contributing to a moderately positive sentiment.

Positives

• A Director's consistent acquisition of company shares, even through a pre-planned program, can signal confidence in the company's future performance and valuation.
• The increase in beneficial ownership by a key insider aligns the director's interests more closely with those of other shareholders.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the director's increased stake as a positive signal of management's belief in the company's future, potentially boosting investor confidence.

Key Dates

Recommendation

The director's consistent acquisition of shares through a pre-planned 10b5-1 program signals confidence in the company's long-term prospects. However, this Form 4 filing alone does not provide sufficient financial or operational details to warrant a stronger buy or sell recommendation. Investors should consider this alongside the company's broader financial performance, market conditions, and strategic outlook before making investment decisions.

Keywords

Cumberland Pharmaceuticals, CPIX, Insider Trading, Form 4, Kenneth Krogulski, Stock Purchase, 10b5-1 Plan, Director Share Acquisition, Pharmaceuticals